CIK 0001623526
- Non-accelerated filer
- Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471144582
- Phone
- +1 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- 4 Open-market sale 10% owner sold 2,000,000 shares at $11.50 ($23,000,000)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 2,586 shares at $12.99 ($33,596)
- 4 Planned sale GENERAL COUNSEL & CORP SEC sold 13,666 shares at an average $13.61 ($185,978)
- 4 Open-market sale CEO sold 6,786 shares at $12.99 ($88,158)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 13,945 shares at $12.78 ($178,182)
- 4 Open-market sale GENERAL COUNSEL & CORP SEC sold 9,696 shares at $12.78 ($123,891)
- 4 Open-market sale CEO sold 6,170 shares at $12.78 ($78,837)
- 4/A Option exercise CEO acquired 26,250 shares (option exercise)
- 4 Option exercise GENERAL COUNSEL & CORP SEC acquired 6,000 shares (option exercise)
- 4 Option exercise CEO acquired 26,500 shares (option exercise)
- 4 Option exercise CHIEF MEDICAL OFFICER acquired 10,000 shares (option exercise)
- 4 Option exercise GENERAL COUNSEL & CORP SEC acquired 33,927 shares (option exercise)
- 4 Option exercise CEO acquired 21,591 shares (option exercise)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 10,000 shares at $12.07 ($120,698)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 10,000 shares at $12.68 ($126,803)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 10,000 shares at $12.06 ($120,648)
- 4 Open-market sale 10% owner sold 1,937,500 shares at $14.05 ($27,221,875)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 10,000 shares at an average $14.95 ($149,481)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 10,000 shares at $14.58 ($145,843)
- 4 Planned sale Chief Business Officer sold 2,500 shares at an average $13.11 ($32,779)
Page 6 of 16 · 305 filings